Serological testing versus other strategies for diagnosis of active tuberculosis in india: A cost-effectiveness analysis

PLoS Medicine

Volumn 8, Issue 8, 2011, Pages

  Dowdy, David W ^a   Steingart, Karen R ^b   Pai, Madhukar ^c  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY DETECTION; ARTICLE; BACTERIAL GROWTH; BACTERIUM CULTURE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; ENZYME LINKED IMMUNOSORBENT ASSAY; HEALTH CARE COST; HUMAN; INDIA; INTERMETHOD COMPARISON; LIFE EXPECTANCY; LIQUID CULTURE; QUALITY ADJUSTED LIFE YEAR; SENSITIVITY ANALYSIS; SENSITIVITY AND SPECIFICITY; SEROLOGY; SPUTUM CYTODIAGNOSIS; SPUTUM SMEAR; THORAX RADIOGRAPHY; TUBERCULOSIS; TUBERCULOSIS CONTROL; ADULT; BLOOD; COMPARATIVE STUDY; COST BENEFIT ANALYSIS; DECISION SUPPORT SYSTEM; ECONOMICS; EPIDEMIOLOGY; IMMUNOLOGY; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MICROSCOPY; MYCOBACTERIUM; PATHOGENICITY; SPUTUM;

BACTERIUM ANTIBODY;

ADULT; ANTIBODIES, BACTERIAL; BACTERIOLOGICAL TECHNIQUES; BIAS (EPIDEMIOLOGY); COST-BENEFIT ANALYSIS; DECISION SUPPORT TECHNIQUES; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; INDIA; MICROSCOPY; MYCOBACTERIUM; SENSITIVITY AND SPECIFICITY; SEROLOGIC TESTS; SPUTUM; TUBERCULOSIS;

EID: 80052331157     PISSN: 15491277     EISSN: 15491676     Source Type: Journal    
DOI: 10.1371/journal.pmed.1001074     Document Type: Article

References (45)

1. Small PM, Pai M, (2010) Tuberculosis diagnosis-time for a game change. N Engl J Med 363: 1070-1071.
2. Perkins MD, Cunningham J, (2007) Facing the crisis: improving the diagnosis of tuberculosis in the HIV era. J Infect Dis 196 (Suppl 1): S15-S27.
3. Keeler E, Perkins MD, Small P, Hanson C, Reed S, et al. (2006) Reducing the global burden of tuberculosis: the contribution of improved diagnostics. Nature 444 (Suppl 1): 49-57.
4. Corbett EL, Watt CJ, Walker N, Maher D, Williams BG, et al. (2003) The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch Intern Med 163: 1009-1021.
5. Gilpin C, Kim SJ, Lumb R, Rieder HL, Van Deun A; Working Group on Sputum Smear Microscopy (2007) Critical appraisal of current recommendations and practices for tuberculosis sputum smear microscopy. Int J Tuberc Lung Dis 11: 946-952.
6. Steingart KR, Ng V, Henry M, Hopewell PC, Ramsay A, et al. (2006) Sputum processing methods to improve the sensitivity of smear microscopy for tuberculosis: A systematic review. Lancet Infect Dis 6: 664-674.
7. Pai M, Ramsay A, O'Brien R, (2008) Evidence-based tuberculosis diagnosis. PLoS Med 5: e156 doi:10.1371/journal.pmed.0050156.
8. Pai M, Minion J, Sohn H, Zwerling A, Perkins MD, (2009) Novel and improved technologies for tuberculosis diagnosis: progress and challenges. Clin Chest Med 30: 701-716.
9. World Health Organization (2010) Framework for implementing new tuberculosis diagnostics. Available: http://www.who.int/tb/laboratory/whopolicyframework_july10_revnov10.pdf. Accessed 13 March 2011.
10. Boehme CC, Nabeta P, Hillemann D, Nicol MP, Shenai S, et al. (2010) Rapid molecular detection of tuberculosis and rifampin resistance. N Engl J Med 363: 1005-1015.
11. World Health Organization (2010) Available: http://whqlibdoc.who.int/publications/2011/9789241501545_eng.pdf. Accessed 13 July 2011.
12. Getahun H, Harrington M, O'Brien R, Nunn P, (2007) Diagnosis of smear-negative pulmonary tuberculosis in people with HIV infection or AIDS in resource-constrained settings: informing urgent policy changes. Lancet 369: 2042-2049.
13. Perkins MD, Roscigno G, Zumla A, (2006) Progress towards improved tuberculosis diagnostics for developing countries. Lancet 367: 942-943.
14. Steingart KR, Flores LL, Dendukuri N, Schiller I, Laal S, et al. (2011) Commercial serological tests for the diagnosis of tuberculosis: an updated systematic review and meta-analysis. PLoS Med 8: e1062 doi:10.1371/journal.pmed.1001062.
15. Grenier J, Pinto L, Nair D, Steingart KR, Dowdy D, et al. (2011) Widespread use of serological tests for tuberculosis: data from 22 high-burden countries. Eur Respir J. In press.
16. World Health Organization (2010) Expert group meeting report on commercial serodiagnostic tests for diagnosis of tuberculosis. Geneva WHO.
17. Dowdy DW, O'Brien MA, Bishai D, (2008) Cost-effectiveness of novel diagnostic tools for the diagnosis of tuberculosis. Int J Tuberc Lung Dis 12: 1021-1029.
18. Joint United Nations Programme on HIV/AIDS (UNAIDS) (2009) AIDS epidemic update 2009. Geneva: UNAIDS/WHO. Report UNAIDS/09.36E/ JC1700E.
19. Special Programme for Research and Training in Tropical Diseases (2008) Diagnostics for tuberculosis: global demand and market potential. Geneva WHO pp. 203 p.
20. Dowdy DW, Lourenco MC, Cavalcante SC, Saraceni V, King B, et al. (2008) Impact and cost-effectiveness of culture for diagnosis of tuberculosis in HIV-infected Brazilian adults. PLos ONE 3: e4057 doi:10.1371/journal.pone.0004057.
21. Mueller DH, Mwenge L, Muyoyeta M, Muvwimi MW, Tembwe R, et al. (2008) Costs and cost-effectiveness of tuberculosis cultures using solid and liquid media in a developing country. Int J Tuberc Lung Dis 12: 1196-1202.
22. Steingart KR, Henry M, Laal S, Hopewell PC, Ramsay A, et al. (2007) Commercial serological antibody detection tests for the diagnosis of pulmonary tuberculosis: a systematic review. PLoS Med 4: e202 doi:10.1371/journal.pmed.0040202.
23. Cruciani M, Scarparo C, Malena M, Bosco O, Serpelloni G, et al. (2004) Meta-analysis of BACTEC MGIT 960 and BACTEC 460 TB, with or without solid media, for detection of mycobacteria. J Clin Microbiol 42: 2321-2325.
24. Styblo K, (1991) Epidemiology of tuberculosis. The Hague, The Netherlands Royal Netherlands Tuberculosis Association (KNCV) pp. 136 p.
25. United States Bureau of Labor Statistics (2010) Consumer price index: all urban consumers. Washington (D.C.): Bureau of Labor Statistics. Available: http://data.bls.gov/cgi-bin/surveymost?cu. Accessed 23 October 2010.
26. World Health Organization (2009) Global tuberculosis control - epidemiology, strategy, financing. Report WHO/HTM/TB/2009.411. Geneva WHO pp. 78 p.
27. Pantoja A, Floyd K, Unnikrishnan KP, Jitendra R, Padma MR, et al. (2009) Economic evaluation of public-private mix for tuberculosis care and control, India. Part I. Socio-economic profile and costs among tuberculosis patients. Int J Tuberc Lung Dis 13: 698-704.
28. Goodchild M, Sahu S, Wares F, Dewan P, Shukla RS, et al. (2011) A cost-benefit analysis of scaling up tuberculosis control in India. Int J Tuberc Lung Dis 15: 358-362.
29. Central Intelligence Agency (2009) The world factbook. Washington (D.C.) Central Intelligence Agency Available:https://www.cia.gov/library/publications/the-world-factbook. Accessed 23 October 2010.
30. Commission on Macroeconomics and Health (2001) Macroeconomics and health: investing in health for economic development. Geneva WHO pp. 200 p.
31. Dowdy DW, Cattamanchi A, Steingart KR, Pai M, (2011) Is scale-up worth it? Challenges in economic analysis of diagnostic tests for tuberculosis. PLoS Med 8: e1001063 doi:10.1371/journal.pmed.1001063.
32. World Health Organization on behalf of the Special Programme for Research and Training in Tropical Diseases (2008) Laboratory-based evaluation of 19 commercially available rapid diagnostic tests for tuberculosis. Geneva World Health Organization pp. 70 p.
33. World Bank (1993) World development report 1993: investing in health. Oxford Oxford University Press pp. 329 p.
34. Dowdy DW, Chaisson RE, Moulton LH, Dorman SE, (2006) The potential impact of enhanced diagnostic techniques for tuberculosis driven by HIV: a mathematical model. AIDS 20: 751-762.
35. Morris K, (2011) WHO recommends against inaccurate tuberculosis tests. Lancet 377: 113-114.
36. Strategic and Technical Advisory Group for Tuberculosis (STAG-TB) (2010) Report of the tenth meeting. Available: http://www.who.int/tb/advisory_bodies/stag_tb_report_2010.pdf. Accessed 13 March 2011.
37. Behr MA, Warren SA, Salamon H, Hopewell PC, Ponce de Leon A, et al. (1999) Transmission of Mycobacterium tuberculosis from patients smear-negative for acid-fast bacilli. Lancet 353: 444-449.
38. Pronyk RM, Makhubele MB, Hargreaves JR, Tollman SM, Hausler HP, (2001) Assessing health seeking behaviour among tuberculosis patients in rural South Africa. Int J Tuberc Lung Dis 5: 619-627.
39. Salaniponi FM, Harries AD, Banda HT, Kang'ombe C, Mphasa N, et al. (2000) Care-seeking behaviour and diagnostic processes in patients with smear-positive pulmonary tuberculosis in Malawi. Int J Tuberc Lung Dis 4: 327-332.
40. Squire SB, Belaye AK, Kashoti A, Salaniponi FM, Mundy CJ, et al. (2005) 'Lost' smear-positive pulmonary tuberculosis cases: where are they and why did we lose them? Int J Tuberc Lung Dis 9: 25-31.
41. Creek TL, Lockman S, Kenyon TA, Makhoa M, Chimidza N, et al. (2000) Completeness and timeliness of treatment initiation after laboratory diagnosis of tuberculosis in Gaborone, Botswana. Int J Tuberc Lung Dis 4: 956-961.
42. Murray CL, Lopez AD, (1996) The global burden of disease: a comprehensive assessment of mortality and disability from diseases, injuries, and risk factors in 1990 and projected to 2020. Boston, Massachusetts Harvard School of Public Health.
43. Ministry of Health and Family Welfare (2010) TB India 2010: RNTCP Status Report. New Delhi: Central TB Division, Directorate General of Health Services (India). Available: http://www.tbcindia.org/pdfs/TB%20India%202010.pdf. Accessed 23 October 2010.
44. Institute of Actuaries of India. Published Mortality Tables. Available: http://www.actuariesindia.org/Publication%20and%20Library%20Facility/mortality%20tables.htm. Accessed 23 October 2010.
45. World Health Organization http://www.who.int/tb/laboratory/policy_statement/en. Accessed: 12 July 2011.